Insider trades
Scott Dreyer, Chief Officer of Collegium Pharmaceutical COLL, has filed 0 purchases and 22 sales on the open market. Over the past 12 months that comes to a net sale of $2.9M. The latest trade was on 03/03.
Scott Dreyer
EVP & Chief Commercial Officer
- First filing
- 23/01/11
- Trades
- 48 trades
- Buys / sales
- 0 / 22
- 12-month net buying
- −$2.9M
- Last trade
- 03/03
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
COLL | Open-market sale10b5-1 plan | 03/03 | 03/05 | 49,976 sh2 trades | $40.40avg. | $2,019,273.53 | −41.0% |
COLL | Open-market sale10b5-1 plan | 25/12/08 | 25/12/10 | 17,600 sh2 trades | $48.17avg. | $847,849.75 | −14.5% |
| Open-market sale10b5-1 plan | 25/08/18 | 25/08/20 | 16,389 sh | $38.21 | $626,223.69 | −13.7% | |
| Open-market sale10b5-1 plan | 25/08/13 | 25/08/15 | 4,861 sh | $38.03 | $184,863.83 | −4.5% | |
COLL | Open-market sale10b5-1 plan | 25/03/20–25/03/21 | 25/03/24 | 20,808 sh2 trades | $30.03avg. | $624,806.43 | −16.7% |
COLL | Open-market sale10b5-1 plan · Amendment | 25/03/11–25/03/14 | 25/03/18 | 17,642 sh2 trades | $30.00avg. | $529,260 | −12.4% |
| Open-market sale10b5-1 plan | 25/03/06 | 25/03/13 | 15,387 sh | $30.00 | $461,610 | −10.8% | |
COLL | Open-market sale10b5-1 plan | 25/03/06–25/03/07 | 25/03/10 | 5,643 sh2 trades | $30.00avg. | $169,290 | −3.8% |
COLL | Open-market sale | 24/05/23–24/05/24 | 24/05/28 | 108,016 sh2 trades | $33.90avg. | $3,662,190.24 | −50.5% |
COLL | Open-market sale10b5-1 plan | 24/02/26 | 24/02/28 | 10,000 sh2 trades | $36.43avg. | $364,311.28 | −6.7% |
| Open-market sale10b5-1 plan | 24/01/16 | 24/01/18 | 23,560 sh | $32.28 | $760,516.8 | −17.5% | |
| Open-market sale | 23/03/01 | 23/03/03 | 13,324 sh | $26.70 | $355,750.8 | −9.0% | |
COLL | Open-market sale | 23/01/09 | 23/01/11 | 17,834 sh3 trades | $27.39avg. | $488,553.97 | −14.8% |